Roth Capital lowered the firm’s price target on Brown-Forman (BF.B) to $35 from $38 and keeps a Buy rating on the shares after its Q4 results. The company closed FY25 with organic growth contraction following expansion in Q3 and 160bps of gross margin erosion after expansion in Q3, the analyst tells investors in a research note. Brown-Forman’s challenging environment is expected to continue, weighing on first FY26 guidance that calls for negative low single digit organic net sales and operating income growth, the firm added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BF.B:
- Brown-Forman price target lowered to $29 from $38 at Deutsche Bank
- Brown-Forman price target lowered to $30 from $38 at Evercore ISI
- Cautious Hold on Brown-Forman B Amid Earnings Miss and Market Challenges
- Brown-Forman price target lowered to $29 from $32 at Morgan Stanley
- Brown-Forman price target lowered to $30 from $44 at RBC Capital